I'm starting to question the rationale behind keeping the pre-clinical results for "unknown" indications in-house.
HIE was completely out of left-field, yet it was identified as being a target of NNZ-2591.
Various posters here have speculated as to what these indications might be and I'm sure some (eg hotrod) will prove to be on the money.
Maybe tomorrow?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.85 |
Change
-0.110(0.85%) |
Mkt cap ! $1.598B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $6.559M | 511.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1657 | $12.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.85 | 6303 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |